Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 101

Sort by

Sort Order Select

Journal Articles

Vaso-Occlusive Crises and Costs of Sickle Cell Disease from a Commercial Payer's Perspective

George J Joseph, Dominick Latremouille-Viau, Vikash Kumar Sharma, Patrick Gagnon-Sanschagrin, Menaka Bhor, PhD, Ankur Khare, Mukesh Kumar Singh, Elizabeth Serra, Mikhail Davidson, Annie Guerin, Nirmish Shah

Blood (2019) 134 (Supplement_1): 3464.

https://doi.org/10.1182/blood-2019-124920

Published: 2019

Journal Articles

A Data-Driven Approach to Define Parsimonious Eligibility Criteria in First-Line Clinical Trials for Diffuse Large B-Cell Lymphoma

R. Andrew Harkins, Sharvil Piyush Patel, Michelle J. Lee, MD PhD, Jeffrey M. Switchenko, PhD MS, Christopher R. Flowers, MD MS

Blood (2019) 134 (Supplement_1): 3416.

https://doi.org/10.1182/blood-2019-125779

Published: 2019

Journal Articles

Safety and Efficacy of 1020 Mg Total Dose Infusion of Ferumoxytol in a Veterans Health System

Paige May, PharmD, Preetika Pai, PharmD, Katherine Boles, PharmD, BCPS, Ashley McGee, PharmD, MBA, BCOP, Jess David Delaune, MD, Tanaka Dang, BS, Jessica M. Schmit, MD

Blood (2019) 134 (Supplement_1): 3538.

https://doi.org/10.1182/blood-2019-130709

Published: 2019

Journal Articles

Pediatric Intensive Care Resource Utilization Following Hematopoietic Cell Transplantation in Children with Acute Leukemia

Cameron Baldes, MD, Martha Wetzel, Courtney McCracken, PhD, Wael Saber, MD MS, Staci D. Arnold, MD MBA, MPH

Blood (2019) 134 (Supplement_1): 3428.

https://doi.org/10.1182/blood-2019-131082

Published: 2019

Journal Articles

Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Christopher Pleyer, MD, Jeffrey Cohen, MD, Susan Soto, Mir Ali, PhD, Inhye E Ahn, MD, Pia Nierman, BSN, MA, RN, Janet Valdez, Jennifer Lotter, PA-C, Jeanine Superata, RN, Xin Tian, Adrian Wiestner, MD PhD, Clare Sun, MD

Blood (2019) 134 (Supplement_1): 3053.

https://doi.org/10.1182/blood-2019-121675

Published: 2019

Journal Articles

Hematologist Experiences and Perceptions of Outpatient Management of Adult Patients with Sickle Cell Disease

Jennifer Yui, MD, Farzana Sayani, MD, Marilyn Schapira, MD

Blood (2019) 134 (Supplement_1): 4710.

https://doi.org/10.1182/blood-2019-131611

Published: 2019

Journal Articles

Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study

Ayman Qasrawi, MD, Richard L O'Neal, MD, Maxwell M. Krem, MD PhD, Gregory Monohan, MD, Reinhold Munker, MD, Gerhard C. Hildebrandt, MD

Blood (2019) 134 (Supplement_1): 4735.

https://doi.org/10.1182/blood-2019-127687

Published: 2019

Journal Articles

Exploring the Needs and Priorities of Black Patients with Lymphoma: A Qualitative Study

Kaylin V. Dance, MPH, Lillian Chen, MPH, Conner B. Imbody, Christopher R. Flowers, MD MS

Blood (2019) 134 (Supplement_1): 5815.

https://doi.org/10.1182/blood-2019-128847

Published: 2019

Journal Articles

Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis

Karen L. Zimowski, MD, Glaivy M. Batsuli, MD, Paulette Bryant, MD, Jenny McDaniel, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 1126.

https://doi.org/10.1182/blood-2019-126659

Published: 2019

Journal Articles

Survivor and Caregiver Perceptions of Lymphoma: A Qualitative Study

Jackelyn B. Payne, MPH, BS, BA, Cathy D. Ho, Lillian Chen, Kaylin V. Dance, Christopher R Flowers, MD MS

Blood (2018) 132 (Supplement 1): 3561.

https://doi.org/10.1182/blood-2018-99-117527

Published: 2018

Journal Articles

Vaccination Adherence in Pediatric Patients Post-Hematopoietic Stem Cell Transplant

Kirshma Khemani, MD, Molly K Steele, Nitya Bakshi, MBBS, MS, Lakshmanan Krishnamurti, MD, Inci Yildirim, MD PhD MSc FAAP

Blood (2018) 132 (Supplement 1): 3406.

https://doi.org/10.1182/blood-2018-99-119283

Published: 2018

Journal Articles

Quality of Care Indicators in Patients with Sickle Cell Disease (SCD): Influenza Vaccination and Routine Eye Examination Are Associated with Outpatient Utilization but Not Acute Hospital Care, Whereas Comorbidity Indexes Are Strongly Associated with Both

Tom Adamkiewicz, MD FRCPC, MSc, Peter Baltrus, PhD, Chaohua Li, MPH, Kitty Carter-Wicker, MD, Anne Gaglioti, MD

Blood (2018) 132 (Supplement 1): 3574.

https://doi.org/10.1182/blood-2018-99-120132

Published: 2018

Journal Articles

First Report of α-Thalassemia Genotypes from Transcaucasia

Gunay Aliyeva, Chingiz Asadov, Tahira Mammadova, Zaur Mammadbayov, Eldar Abdulalimov, Surmaya Gafarova

Blood (2018) 132 (Supplement 1): 4899.

https://doi.org/10.1182/blood-2018-99-110285

Published: 2018

Journal Articles

Trends in Multiple Myeloma Incidence in the United States (US): Demographic and Geographic Considerations and Focus on Young Adults

Gordon Ruan, MD, Gaurav Goyal, MBBS, Shahrukh K. Hashmi, MD MPH, Prashant Kapoor, MD, Ronald S. Go, MD

Blood (2018) 132 (Supplement 1): 5575.

https://doi.org/10.1182/blood-2018-99-114105

Published: 2018

Journal Articles

Priorities for Rural Lymphoma Survivors: An Exploratory Study

Jackelyn B. Payne, MPH, BS, BA, Lillian Chen, Cathy D. Ho, Kaylin V. Dance, Andrew Ritter, MD, Christopher R Flowers, MD MS

Blood (2018) 132 (Supplement 1): 4789.

https://doi.org/10.1182/blood-2018-99-117642

Published: 2018

Journal Articles

A Normal Prothrombin Time, Activated Partial Thromboplastin Time and Fibrinogen Level Do Not Eliminate Disseminated Intravascular Coagulation (DIC) and Bleeding Risk in Patients with Acute Promyelocytic Leukemia

Kathryn Sarah Simon, PA-C, Prachi Kharkhanis, Catherine R. Caprara, MSN, NP, Stephanie Debragga, Sheldon Bolds, Saleh Alghsoon, Martha L. Arellano, MD, Ravindra Kolhe, MD PhD, Anand Jillella, MD, Vamsi Kota, MBBS

Blood (2017) 130 (Supplement 1): 4869.

https://doi.org/10.1182/blood.V130.Suppl_1.4869.4869

Published: 2017

Journal Articles

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Rebecca Kruse-Jarres, Michael U. Callaghan, Stacy E. Croteau, MD, Victor Jimenez-Yuste, Liane Khoo, Ri Liesner, Tadashi Matsushita, Michael Recht, Guy Young, Tiffany Chang, Christophe Dhalluin, Yunming Mu, Jin Xu, Jenny Devenport, Richard H. Ko, Paul Solari, Johannes Oldenburg

Blood (2017) 130 (Supplement 1): 89.

https://doi.org/10.1182/blood.V130.Suppl_1.89.89

Published: 2017

Journal Articles

Acute Promyelocytic Leukemia (APL) Induction Therapy and Incidence of Renal Insufficiency

Prachi Kharkhanis, Sheldon Bolds, Stephanie Debragga, Catherine R. Caprara, MSN, NP, Kathryn Sarah Simon, PA-C, Martha L. Arellano, MD, Anand Jillella, MD, Vamsi Kota, MBBS

Blood (2017) 130 (Supplement 1): 5020.

https://doi.org/10.1182/blood.V130.Suppl_1.5020.5020

Published: 2017

Journal Articles

Utility of D-Dimer LEVEL As a Marker for Differentiation Syndrome, Infection, and Death in ACUTE Promyelocytic Leukemia (APL)

Catherine R. Caprara, MSN, NP, Prachi Kharkhanis, Kathryn Sarah Simon, PA-C, Stephanie Debragga, Sheldon Bolds, Martha L. Arellano, MD, Anand Jillella, MD, Vamsi Kota, MBBS

Blood (2017) 130 (Supplement 1): 5071.

https://doi.org/10.1182/blood.V130.Suppl_1.5071.5071

Published: 2017

Journal Articles

Practical Application of the Athndataset: Evaluating Uptake of Extended Half-Life Factor Concentrates in Patients with Moderate and Severe Hemophilia

Stacy E. Croteau, MD, Dunlei Cheng, PhD, Alice J. Cohen, MD, Chris E. Holmes, MD PhD, Peter A. Kouides, MD, Leslie J Raffini, MD MSCE, Michael Silvey, DO, Courtney Thornburg, MD, Allison P. Wheeler, MD, Ellis J Neufeld, MD PhD

Blood (2017) 130 (Supplement 1): 23.

https://doi.org/10.1182/blood.V130.Suppl_1.23.23

Published: 2017

NARROW

Vaso-Occlusive Crises and Costs of Sickle Cell Disease from a Commercial Payer's Perspective

A Data-Driven Approach to Define Parsimonious Eligibility Criteria in First-Line Clinical Trials for Diffuse Large B-Cell Lymphoma

Safety and Efficacy of 1020 Mg Total Dose Infusion of Ferumoxytol in a Veterans Health System

Pediatric Intensive Care Resource Utilization Following Hematopoietic Cell Transplantation in Children with Acute Leukemia

Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Hematologist Experiences and Perceptions of Outpatient Management of Adult Patients with Sickle Cell Disease

Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study

Exploring the Needs and Priorities of Black Patients with Lymphoma: A Qualitative Study

Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis

Survivor and Caregiver Perceptions of Lymphoma: A Qualitative Study

Vaccination Adherence in Pediatric Patients Post-Hematopoietic Stem Cell Transplant

Quality of Care Indicators in Patients with Sickle Cell Disease (SCD): Influenza Vaccination and Routine Eye Examination Are Associated with Outpatient Utilization but Not Acute Hospital Care, Whereas Comorbidity Indexes Are Strongly Associated with Both

First Report of α-Thalassemia Genotypes from Transcaucasia

Trends in Multiple Myeloma Incidence in the United States (US): Demographic and Geographic Considerations and Focus on Young Adults

Priorities for Rural Lymphoma Survivors: An Exploratory Study

A Normal Prothrombin Time, Activated Partial Thromboplastin Time and Fibrinogen Level Do Not Eliminate Disseminated Intravascular Coagulation (DIC) and Bleeding Risk in Patients with Acute Promyelocytic Leukemia

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Acute Promyelocytic Leukemia (APL) Induction Therapy and Incidence of Renal Insufficiency

Utility of D-Dimer LEVEL As a Marker for Differentiation Syndrome, Infection, and Death in ACUTE Promyelocytic Leukemia (APL)

Practical Application of the Athndataset: Evaluating Uptake of Extended Half-Life Factor Concentrates in Patients with Moderate and Severe Hemophilia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only